equityflowunderstand the flow and follow it
EquityFlowCompanies › Science

Science

Healthtech · US

US neural-engineering company building the PRIMA retinal implant and brain-computer interfaces.

Founders

Team & hubs

In the network

Shares the most investors with (number = shared investors):

Funding history

DateRoundAmount
Mar 2026Series C
Neural-engineering startup Science raised a $230M Series C to commercialise its PRIMA retinal implant and expand clinical trials.
$230M

Investors

Tap an investor to see what else they have backed.

Other companies in Healthtech

Other companies in US

Other companies at Series C stage

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.